APA (7th ed.) Citation

Alba, E., Albanell, J., de la Haba, J., Barnadas, A., Calvo, L., Sánchez-Rovira, P., . . . Lluch, A. (2014). Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: Results from the GEICAM/2006-14 trial. British Journal of Cancer, 110(5), 1139. https://doi.org/10.1038/bjc.2013.831

Chicago Style (17th ed.) Citation

Alba, E., et al. "Trastuzumab or Lapatinib with Standard Chemotherapy for HER2-positive Breast Cancer: Results from the GEICAM/2006-14 Trial." British Journal of Cancer 110, no. 5 (2014): 1139. https://doi.org/10.1038/bjc.2013.831.

MLA (9th ed.) Citation

Alba, E., et al. "Trastuzumab or Lapatinib with Standard Chemotherapy for HER2-positive Breast Cancer: Results from the GEICAM/2006-14 Trial." British Journal of Cancer, vol. 110, no. 5, 2014, p. 1139, https://doi.org/10.1038/bjc.2013.831.